Tri Locum Partners LP Syndax Pharmaceuticals Inc Transaction History

Tri Locum Partners LP

  • $387 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$13.42 - $25.18 $2.42 Million - $4.54 Million
-180,261 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$19.28 - $24.59 $1.18 Million - $1.51 Million
61,428 Added 51.69%
180,261 $4.03 Million
Q4 2020

Feb 16, 2021
BUY
$15.1 - $26.44 $1.79 Million - $3.14 Million
118,833 New
118,833 $2.64 Million

Others Institutions Holding SNDX

# of Institutions
199
Shares Held
87M
Call Options Held
268K
Put Options Held
76.8K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $1.07B
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email